Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among HIV-infected Children and Adolescents

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Adverse Bone HealthHIV Infection
Interventions
DIETARY_SUPPLEMENT

High dose vitamin D and calcium

participants will receive a FDC tablet containing 1500 mg of calcium carbonate (equivalent to 600 mg of elemental calcium) and 200 IU of vitamin D3. This drug will be administered as 1 tablet orally twice daily and is to be taken with food. In addition, participants will receive vitamin D2 capsule containing 20,000 IU of ergocalciferol, which will be administered as 1 capsule orally once weekly at any time (not related with meal).

DIETARY_SUPPLEMENT

Normal dose vitamin D and calcium

participants will receive a FDC tablet containing 1500 mg of calcium carbonate (equivalent to 600 mg of elemental calcium) and 200 IU of vitamin D3. This drug will be administered as 1 tablet orally twice daily and is to be taken with food

Trial Locations (5)

10330

HIV-NAT, Thai Red Cross - AIDS Research Centre, Bangkok

50200

Faculty of Medicine and Research Institute for Health Sciences (RIHES), Chiang Mai University, Chiang Mai

50700

Chiangrai Prachanukroh Hospital, Chiang Rai

Unknown

Queen Sirikit National Institute of Child Health, Bangkok

Nakornping hospital (NKP), Chiang Mai

All Listed Sponsors
collaborator

HIV-NAT, Thai Red Cross - AIDS Research Centre

UNKNOWN

collaborator

Nakornping Hospital

OTHER

lead

Chiang Mai University

OTHER

NCT02426840 - Calcium and High-dose Vitamin D Supplementation on Bone Mineral Density Among HIV-infected Children and Adolescents | Biotech Hunter | Biotech Hunter